Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
The incorporation of a ruthenium catalyst and carbon fluorinated moieties into polymeric nanoreactors is expected to provide an anticancer strategy for tumor-targeted catalytic anticancer therapy of hypoxic tumors
The writing committee included representatives from the AHA, ACC, American Diabetes Association (ADA), including ADA Obesity Alliance representation, and the American Society of Nephrology
Current Pharmaceutical Design , 24(18), 19902001
Initially, 1,622,199 adult individuals with MASLD were identified, of which 129,534 new users of either GLP-1 RA + SGLT2i (n = 35,187) or SGLT2i alone (n = 94,347) were selected
US$ 29.27
US$ 20.15
US$ 28.45
US$ 25.26
